SARS-CoV-2 Antibody Lateral Flow Assay for antibody prevalence studies following vaccine roll out: a Diagnostic Accuracy Study
Alexandra Cann, Candice Clarke, Jonathan Brown, Tina Thomson, Maria Prendecki, Maya Moshe, Anjna Badhan, View ORCID ProfilePaul Elliott, Ara Darzi, Steven Riley, Deborah Ashby, Michelle Willicombe, Peter Kelleher, Paul Randell, Helen Ward, Wendy S Barclay, Graham Cooke
doi: https://doi.org/10.1101/2021.07.14.21260488
Alexandra Cann
1Department of Infectious Disease, Imperial College London, UK
2Imperial College Healthcare NHS Trust, UK
Candice Clarke
3Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London
4Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital
Jonathan Brown
1Department of Infectious Disease, Imperial College London, UK
Tina Thomson
Maria Prendecki
3Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London
4Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital
Maya Moshe
1Department of Infectious Disease, Imperial College London, UK
Anjna Badhan
1Department of Infectious Disease, Imperial College London, UK
Paul Elliott
1Department of Infectious Disease, Imperial College London, UK
2Imperial College Healthcare NHS Trust, UK
5School of Public Health, Imperial College London, UK
7National Institute for Health Research Imperial Biomedical Research Centre, UK
Ara Darzi
1Department of Infectious Disease, Imperial College London, UK
2Imperial College Healthcare NHS Trust, UK
7National Institute for Health Research Imperial Biomedical Research Centre, UK
Steven Riley
1Department of Infectious Disease, Imperial College London, UK
6MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
Deborah Ashby
1Department of Infectious Disease, Imperial College London, UK
5School of Public Health, Imperial College London, UK
Michelle Willicombe
3Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London
4Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital
Peter Kelleher
1Department of Infectious Disease, Imperial College London, UK
8Chelsea and Westminster Foundation NHS Trust
Paul Randell
2Imperial College Healthcare NHS Trust, UK
9Department of Infectious Disease, Imperial College London, London, UK; Jefferiss Research Trust Laboratories
Helen Ward
1Department of Infectious Disease, Imperial College London, UK
2Imperial College Healthcare NHS Trust, UK
5School of Public Health, Imperial College London, UK
6MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
7National Institute for Health Research Imperial Biomedical Research Centre, UK
Wendy S Barclay
1Department of Infectious Disease, Imperial College London, UK
Graham Cooke
1Department of Infectious Disease, Imperial College London, UK
2Imperial College Healthcare NHS Trust, UK
7National Institute for Health Research Imperial Biomedical Research Centre, UK
FRCPData Availability
Harvard Dataverse Repository: "Replication Data for: SARS-CoV-2 Antibody Lateral Flow Assay for Possible Use in Seroprevalence Surveys: a Diagnostic Accuracy Study", https://doi.org/10.7910/DVN/KCDZIN, This project contains the following underlying data: - Anti Spike Protein LFIA For HCW Cohort - Anti Spike Protein LFIA For Renal Cohort - Neutralisation Titres for HCW Cohort
Posted July 16, 2021.
SARS-CoV-2 Antibody Lateral Flow Assay for antibody prevalence studies following vaccine roll out: a Diagnostic Accuracy Study
Alexandra Cann, Candice Clarke, Jonathan Brown, Tina Thomson, Maria Prendecki, Maya Moshe, Anjna Badhan, Paul Elliott, Ara Darzi, Steven Riley, Deborah Ashby, Michelle Willicombe, Peter Kelleher, Paul Randell, Helen Ward, Wendy S Barclay, Graham Cooke
medRxiv 2021.07.14.21260488; doi: https://doi.org/10.1101/2021.07.14.21260488
SARS-CoV-2 Antibody Lateral Flow Assay for antibody prevalence studies following vaccine roll out: a Diagnostic Accuracy Study
Alexandra Cann, Candice Clarke, Jonathan Brown, Tina Thomson, Maria Prendecki, Maya Moshe, Anjna Badhan, Paul Elliott, Ara Darzi, Steven Riley, Deborah Ashby, Michelle Willicombe, Peter Kelleher, Paul Randell, Helen Ward, Wendy S Barclay, Graham Cooke
medRxiv 2021.07.14.21260488; doi: https://doi.org/10.1101/2021.07.14.21260488
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (623)
- Anesthesia (162)
- Cardiovascular Medicine (2335)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11694)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3679)
- Geriatric Medicine (345)
- Health Economics (630)
- Health Informatics (2361)
- Health Policy (925)
- Hematology (339)
- HIV/AIDS (772)
- Medical Education (363)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3436)
- Nursing (194)
- Nutrition (519)
- Oncology (1800)
- Ophthalmology (533)
- Orthopedics (216)
- Otolaryngology (285)
- Pain Medicine (230)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6084)
- Radiology and Imaging (1254)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)